Abstract
Lentiviral transduction is a highly efficient DNA delivery method for RNA interference applications. However, obtaining high lentiviral titers of shRNA and miRNA encoding vectors is challenging, since shRNA and miRNA cassettes have been shown to reduce lentiviral titers. In this study, we compare four commercially available packaging mixes and two producer cell lines in order to optimize lentiviral production for gene silencing experiments. Lentiviral vectors encoding a miRNA sequence and emerald green fluorescence protein were co-transfected with ViraPower™, Lenti-X™ HTX, MISSION® Lentiviral or Trans-Lentiviral™ packaging mix in HEK-293T or 293FT cells. After transducing HeLa cells with virus-containing supernatant, lentiviral titers were determined by flow cytomerty. In both cell lines, the highest lentiviral titer was obtained with MISSION® Lentiviral packaging mix, followed by ViraPower™, Lenti-X™ HTX, and Trans-Lentiviral™. On average, HEK-293T cells produced 6.2-fold higher lentiviral titers than 293FT cells (p < 0.001). With the combination of MISSION® Lentiviral packaging mix and HEK-293T cells, an up to 48.5-fold higher lentiviral titer was reached compared to other packaging mixes and producer cell lines. The optimized selection of packaging mix and cell line described in this work should facilitate the production of high-titer lentiviruses for gene silencing experiments.
Similar content being viewed by others
References
Cao, F., Xie, X., Gollan, T., Zhao, L., Narsinh, K., Lee, R. J., & Wu, J. C. (2010). Comparison of gene-transfer efficiency in human embryonic stem cells. Molecular imaging and biology. MIB, 12, 15–24.
Li, G. B., & Lu, G. X. (2009). Gene delivery efficiency in bone marrow-derived dendritic cells: Comparison of four methods and optimization for lentivirus transduction. Molecular Biotechnology, 43, 250–256.
Follenzi, A., & Naldini, L. (2002). Generation of HIV-1 derived lentiviral vectors. Methods in Enzymology, 346, 454–465.
Baekelandt, V., Claeys, A., Eggermont, K., Lauwers, E., De Strooper, B., Nuttin, B., & Debyser, Z. (2002). Characterization of lentiviral vector-mediated gene transfer in adult mouse brain. Human Gene Therapy, 13, 841–853.
Geraerts, M., Willems, S., Baekelandt, V., Debyser, Z., & Gijsbers, R. (2006). Comparison of lentiviral vector titration methods. BMC Biotechnology, 6, 34.
Bartlett, D. W., & Davis, M. E. (2006). Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Research, 34, 322–333.
Abbas-Terki, T., Blanco-Bose, W., Deglon, N., Pralong, W., & Aebischer, P. (2002). Lentiviral-mediated RNA interference. Human Gene Therapy, 13, 2197–2201.
Mayoral, R. J., & Monticelli, S. (2010). Stable overexpression of miRNAs in bone marrow-derived murine mast cells using lentiviral expression vectors. Methods in Molecular Biology, 667, 205–214.
Liu, Y. P., Vink, M. A., Westerink, J. T., Ramirez de Arellano, E., Konstantinova, P., Ter Brake, O., & Berkhout, B. (2010). Titers of lentiviral vectors encoding shRNAs and miRNAs are reduced by different mechanisms that require distinct repair strategies. RNA, 16, 1328–1339.
Lee, Y., Kim, M., Han, J., Yeom, K. H., Lee, S., Baek, S. H., & Kim, V. N. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO Journal, 23, 4051–4060.
Bohnsack, M. T., Czaplinski, K., & Gorlich, D. (2004). Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA, 10, 185–191.
Han, J., Lee, Y., Yeom, K. H., Kim, Y. K., Jin, H., & Kim, V. N. (2004). The Drosha-DGCR8 complex in primary microRNA processing. Genes & Development, 18, 3016–3027.
Yi, R., Qin, Y., Macara, I. G., & Cullen, B. R. (2003). Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes & Development, 17, 3011–3016.
Chapman, E. J., & Carrington, J. C. (2007). Specialization and evolution of endogenous small RNA pathways. Nature Reviews Genetics, 8, 884–896.
Schwarz, D. S., Hutvagner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003). Asymmetry in the assembly of the RNAi enzyme complex. Cell, 115, 199–208.
Ambros, V. (2004). The functions of animal microRNAs. Nature, 431, 350–355.
Poluri, A., & Sutton, R. E. (2008). Titers of HIV-based vectors encoding shRNAs are reduced by a dicer-dependent mechanism. Molecular Therapy, 16, 378–386.
Higashimoto, T., Urbinati, F., Perumbeti, A., Jiang, G., Zarzuela, A., Chang, L. J., et al. (2007). The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors. Gene Therapy, 14, 1298–1304.
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell, 101, 173–185.
Shen, P. C., Lu, C. S., Shiau, A. L., Lee, C. H., Jou, I. M., & Hsieh, J. L. (2013). Lentiviral small hairpin RNA knockdown of macrophage inflammatory protein-1 gamma ameliorates experimentally induced osteoarthritis in mice. Human Gene Therapy, 24, 871–882.
Torrisani, J., Bournet, B., du Rieu, M. C., Bouisson, M., Souque, A., Escourrou, J., et al. (2009). let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Human Gene Therapy, 20, 831–844.
Sindhu, A., Arora, P., & Chaudhury, A. (2012). Illuminating the gateway of gene silencing: Perspective of RNA interference technology in clinical therapeutics. Molecular Biotechnology, 51, 289–302.
Singh, N. K., Meshram, C. D., Sonwane, A. A., Dahiya, S. S., Pawar, S. S., Chaturvedi, V. K., et al. (2014). Protection of mice against lethal rabies virus challenge using short interfering RNAs (siRNAs) delivered through lentiviral vector. Molecular Biotechnology, 56, 91–101.
Feeley, B. T., Conduah, A. H., Sugiyama, O., Krenek, L., Chen, I. S., & Lieberman, J. R. (2006). In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models. Journal of Orthopaedic Research, 24, 1709–1721.
Logan, A. C., Nightingale, S. J., Haas, D. L., Cho, G. J., Pepper, K. A., & Kohn, D. B. (2004). Factors influencing the titer and infectivity of lentiviral vectors. Human Gene Therapy, 15, 976–988.
Karolewski, B. A., Watson, D. J., Parente, M. K., & Wolfe, J. H. (2003). Comparison of transfection conditions for a lentivirus vector produced in large volumes. Human Gene Therapy, 14, 1287–1296.
Cribbs, A. P., Kennedy, A., Gregory, B., & Brennan, F. M. (2013). Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells. BMC Biotechnology, 13, 98.
Hewinson, J., Paton, J. F., & Kasparov, S. (2013). Viral gene delivery: Optimized protocol for production of high titer lentiviral vectors. Methods in Molecular Biology, 998, 65–75.
Chen, Q., Zhu, T., Jones, G., Zhang, J., & Sun, Y. (2013). First knockdown gene expression in bat (Hipposideros armiger) brain mediated by lentivirus. Molecular Biotechnology, 54, 564–571.
Denning, W., Das, S., Guo, S., Xu, J., Kappes, J. C., & Hel, Z. (2013). Optimization of the transductional efficiency of lentiviral vectors: Effect of sera and polycations. Molecular Biotechnology, 53, 308–314.
Liu, Y., Zhou, J., Pan, J. A., Mabiala, P. & Guo, D. (2014). A novel approach to block HIV-1 coreceptor CXCR4 in non-toxic manner. Molecular Biotechnology, 56, 890–902.
Madonna, R., Bolli, R., Rokosh, G., & De Caterina, R. (2013). Long-term engraftment and angiogenic properties of lentivirally transduced adipose tissue-derived stromal cells. Molecular Biotechnology, 54, 13–24.
Conflict of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Albrecht, C., Hosiner, S., Tichy, B. et al. Comparison of Lentiviral Packaging Mixes and Producer Cell Lines for RNAi Applications. Mol Biotechnol 57, 499–505 (2015). https://doi.org/10.1007/s12033-015-9843-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-015-9843-8